The Fundraising Efforts of T dot RX

This chapter discusses the fundraising efforts of a new biotech firm called T dot RX, comparing the amount they are looking to raise with other first funds in the industry. It also explores the value proposition of T dot RX, which is the proximity to renowned scientist Bob Langer, and discusses the close relationships between biotech entrepreneurs and certain firms when it comes to funding.